Cagent Vascular published a case report by Dr. Michael Campbell detailing Serration Remodeling Therapy (SRT) in an above-the-knee treatment algorithm.

Cagent Vascular is the first and only company to commercialize an angioplasty balloon with integrated serrations, introducing a new category of endovascular treatment: Serration Remodeling Therapy (SRT). Headquartered in Wayne, PA, our mission is to improve outcomes for patients with Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI) by changing the way physicians treat diseased vessels. Our flagship device, the Serranator® PTA Serration Balloon Catheter, creates controlled micro-fissures in the arterial wall, driving vessel wall remodeling, not just dilation. The result: greater lumen gain, reduced recoil, and improved vessel compliance across lesion morphologies. It's time for a new standard of care. It starts with Serranator.